未登录

H

Haoyi Zhou

peking university third hospital

H指数:6

被引数:155

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types

工程化力敏MSCs实现跨肿瘤类型的合成放射性诊疗靶向

IF20.4

2026-08-200

PRE

ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy

ICAM-1促进T细胞糖酵解重编程和肿瘤浸润，从而驱动放疗后的18F-FDG PET爆发

IF0

2026-02-010

OA

A Nanoradiosensitizer Potentiates Tumor Radiotherapy through JFK Inhibition and Hypoxia Alleviation

一种纳米放射增敏剂通过JFK抑制和缺氧缓解增强肿瘤放射治疗

IF9.1

2025-03-240

PRE

68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trial

NATURE COMMUNICATIONS

IF15.7

2024-10-100

OAAI

Targeted protein degradation combined with PET imaging reveals the role of host PD-L1 in determining anti-PD-1 therapy efficacy

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2024-06-240

PRE

Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-03-210

OA

Annotation of CD8+T-cell function via ICAM-1 imaging identifies FAK inhibition as an adjuvant to augment the antitumor immunity of radiotherapy

IF13.3

2024-01-014

OAAI

Noninvasive interrogation of CD8+T cell effector function for monitoring early tumor responses to immunotherapy

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2022-08-1520

OAAI

Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2022-02-0210

PRE

ICAM-1 orchestrates the abscopal effect of tumor radiotherapy

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2021-03-3033

OA